Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Marie Annick Dugué"'
Publikováno v:
Revue Francophone des Laboratoires. 2009:35-48
Resume La principale hormone glucocorticoide est le cortisol produit par la corticosurrenale sous l’action stimulante de l’hormone corticotrope hypophysaire (ACTH), elle-meme sous la dependance des peptides hypothalamiques, la corticoliberine (CR
Autor:
Jérôme Bertherat, Lionel Groussin, Vivian Viallon, Gwenaelle Abiven-Lepage, Marie Annick Dugué, Catarina B d'Alva, Xavier Bertagna
Publikováno v:
European Journal of Endocrinology. 159:641-647
ObjectiveAdrenocortical tumors (ACT) account for no more than 0.2% of the causes of androgen excess (AE). Conversely, these rare tumors have a very poor prognosis. It is difficult and important to exclude this diagnosis whenever there is AE.DesignRet
Autor:
Xavier Bertagna, Paul Legmann, Guillaume Assié, Foued Karray, Jérôme Bertherat, Stéphane Silvera, Michèle Kujas, Joël Coste, Hélène Bahurel, Marie Annick Dugué, Bertrand Dousset
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 92:172-179
Context: Adrenalectomy is a radical treatment for hypercortisolism in Cushing’s disease. However, it may lead to Nelson’s syndrome, originallydefinedbytheassociationofapituitarymacroadenomaand high plasma ACTH concentrations, a much feared compli
Autor:
Marie-Annick Dugué, Jean-Pierre Luton, Pierre Thomopoulos, Zina Barrou, Dominique Guiban, Amel Maroufi, Claudine Fournier
Publikováno v:
European Journal of Endocrinology. 134:93-96
Barrou Z, Guiban D, Maroufi A, Fournier C, Dugué M-A, Luton J-P. Thomopoulos P. Overnight dexamethasone suppression test: comparison of plasma and salivary cortisol measurement for the screening of Cushing's syndrome. Eur J Endocrinol 1996:134:93–
Autor:
Xavier Bertagna, Stéphane Gaillard, Jérôme Bertherat, Marie Annick Dugué, Joël Coste, Carmen A. Carrasco, Laurence Guignat, Lionel Groussin
Publikováno v:
The Journal of clinical endocrinology and metabolism. 93(12)
Midnight salivary cortisol (MSC) is now recognized as a reliable index for Cushing's syndrome diagnosis but has to be validated for the follow-up of treated patients.Our objective was to evaluate MSC for assessing the outcome of transsphenoidal surge